All Articles

Eric Hinson, a pilot and strategist, returns to lead FlightSafety. Can his unique blend of operational expertise and market savvy reshape aviation training?

As major cryptos stagnate, GeeFi's $1M+ presale captures investor interest with a vision for an all-in-one ecosystem, but faces scrutiny over risks.

Sarah Belliveau's Forbes honor is more than an award; it’s a signal of a firm culture and strategy thriving amidst industry-wide disruption.

Urbanfund Corp. just unlocked over $8M in capital by refinancing a Toronto asset. Here's what this savvy move signals about its growth plans and the market.

Guggenheim's latest fund distributions include a 'return of capital.' We break down what this means for your tax bill and what it signals about the market.

A century-old hauler's acquisition by IWS reveals the new reality of NYC's waste industry, driven by green tech, regulation, and massive consolidation.

Precision Aerospace & Defense is going public via a SPAC deal, unlocking capital to consolidate a fragmented A&D supply chain and expand its reach.

Wabtec's major acquisition isn't just another deal; it's a strategic move to dominate the future of smart railways. Here's why it matters.

The retail REIT is paying a higher interest rate to extend its debt maturity to 2035, a strategic move signaling confidence in a shifting market.

Alaris Equity Partners shatters deployment records with a $92M debenture offering and a key US$30M investment into the resilient healthcare sector.

A landmark deal for fertilizer giant Profertil reveals a strategic play to control the infrastructure of food production, from natural gas to the dinner plate.

Commercial Metals Company's $675M acquisition of CP&P and pending Foley deal signal a major pivot, creating a precast concrete leader for an infrastructure boom.

South Plains Financial's acquisition of Bank of Houston goes beyond the numbers, betting on shared values and community focus to redefine banking in Texas.

Record Q3 results fuel Volatus Aerospace's expansion in defense and commercial drones, with a strategic focus on Canadian manufacturing and supply chains.

Genmab's routine insider transaction report isn't just regulatory noise. It reveals how data-driven innovation is tied to long-term executive strategy.

Companion Spine’s acquisition of Paradigm Spine is more than a deal; it’s a masterstroke by the Viscogliosi Brothers to dominate the future of spine surgery.

Amneal secures FDA approval for its generic Restasis, targeting a $2B market. But can its manufacturing strategy overcome late entry and quality concerns?

Beyond a simple refi, Ducommun’s new credit line is a strategic power play, positioning the A&D supplier to hunt for acquisitions and execute its VISION 2027.

Global consultancy Adastra is among the first to earn AWS's new Agentic AI Specialization, marking a pivotal move from AI hype to real-world automation.

A new probiotic for adults 50+ targets memory and muscle strength, signaling a strategic shift into the booming, science-driven healthy aging industry.